JNJ

226.12

+0.1%↑

UNH

366.23

-0.28%↓

TMO

464.26

-0.74%↓

ISRG

453.69

-0.41%↓

ABT

86.9

-2.39%↓

JNJ

226.12

+0.1%↑

UNH

366.23

-0.28%↓

TMO

464.26

-0.74%↓

ISRG

453.69

-0.41%↓

ABT

86.9

-2.39%↓

JNJ

226.12

+0.1%↑

UNH

366.23

-0.28%↓

TMO

464.26

-0.74%↓

ISRG

453.69

-0.41%↓

ABT

86.9

-2.39%↓

JNJ

226.12

+0.1%↑

UNH

366.23

-0.28%↓

TMO

464.26

-0.74%↓

ISRG

453.69

-0.41%↓

ABT

86.9

-2.39%↓

JNJ

226.12

+0.1%↑

UNH

366.23

-0.28%↓

TMO

464.26

-0.74%↓

ISRG

453.69

-0.41%↓

ABT

86.9

-2.39%↓

Kodu・Aktsiate loetelu・WaVe Life Sciences Ltd

Search

WaVe Life Sciences Ltd

Avatud

7.3 3.25

Ülevaade

Aktsiahinna muutus

24h

Praegune

Min

7.28

Max

7.38

Põhinäitajad
By Trading Economics
Sissetulek	673K -53M
Müük	9.6M 17M
Kasumimarginaal	-308.373
Töötajad	317
EBITDA	705K -51M

Soovitused
By TipRanks
Soovitused	Tugev "osta" hinnang
12 kuu keskmine prognoos	+233.33% upside

Dividendid
By Dow Jones
Järgmine tulemuste avaldamine	29. juuli 2026

Turustatistika
By TradingEconomics
Turukapital	-1.2B 1.3B
Eelmine avamishind	4.05
Eelmine sulgemishind	7.3

Tehniline skoor

By Trading Central

Kindlus

Very Strong Bearish Evidence

6.35 / 6.555 Toetus ja vastupanu

WaVe Life Sciences Ltd Graafik

Mineviku tootlus ei ole usaldusväärne näitaja tulevaste tulemuste kohta.

Seotud uudised

4. mai 2026, 22:17 UTC

Tulu

Australia's Westpac Lifts Dividend as 1st Half Profit Rises 2.7%

4. mai 2026, 23:47 UTC

Tulu

Grab Holdings 1Q Adj EBITDA $154.0M Vs. $106.0M >GRAB

4. mai 2026, 23:45 UTC

Tulu

Grab Holdings 1Q Rev $955.0M Vs. $773.0M >GRAB

4. mai 2026, 23:45 UTC

Tulu

Grab Holdings 1Q Net $120.0M Vs. Net $10.0M >GRAB

4. mai 2026, 23:40 UTC

Market Talk

Gold Steady Amid Likely Technical Recovery -- Market Talk

4. mai 2026, 22:44 UTC

Omandamised, ülevõtmised, äriostud

Regis: Jim Beyer To Be Chief Executive of Combined Company

4. mai 2026, 22:43 UTC

Omandamised, ülevõtmised, äriostud

Regis: Russell Clark To Be Nonexecutive Chairman of Combined Company

4. mai 2026, 22:42 UTC

Omandamised, ülevõtmised, äriostud

Regis: Companies Expect to Realize Over A$500 Million in Corporate Tax Benefits

4. mai 2026, 22:42 UTC

Omandamised, ülevõtmised, äriostud

Regis: Combined Company to Have Strong, Debt-Free Balance Sheet; Significant Cash Generation

4. mai 2026, 22:41 UTC

Omandamised, ülevõtmised, äriostud

Regis: Combined Company to Have Annual Production of More Than 700,000 Oz

4. mai 2026, 22:41 UTC

Omandamised, ülevõtmised, äriostud

Regis: Pro Forma Market Capitalization About A$10.7 Billion

4. mai 2026, 22:40 UTC

Omandamised, ülevõtmised, äriostud

Regis: Shareholders to Own About 51% of Combined Company

4. mai 2026, 22:40 UTC

Omandamised, ülevõtmised, äriostud

Regis: Board Unanimously Endorsed, Supported Deal

4. mai 2026, 22:40 UTC

Omandamised, ülevõtmised, äriostud

Regis: Deal Unanimously Recommended by Vault Board

4. mai 2026, 22:39 UTC

Omandamised, ülevõtmised, äriostud

Regis: Vault Shareholders to Receive 0.6947 New Shares in Regis For Each Vault One Held

4. mai 2026, 22:38 UTC

Omandamised, ülevõtmised, äriostud

Regis Resources to Acquire All Ordinary Shares in Vault

4. mai 2026, 22:38 UTC

Omandamised, ülevõtmised, äriostud

Regis Resources, Vault Minerals Agree to Merger of Equals

4. mai 2026, 22:37 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- 2nd Update

4. mai 2026, 22:26 UTC

Tulu

Omandamised, ülevõtmised, äriostud

Palantir Beats Forecasts With $1.63 Billion Quarter as Sales Accelerate -- Update

4. mai 2026, 22:02 UTC

Tulu

Australia's Westpac Lifts Dividend as 1H Profit Rises 2.7%

4. mai 2026, 22:00 UTC

Market Talk

BOC's Macklem: Conditions To Dictate Fuel-Price Response -- Market Talk

4. mai 2026, 21:52 UTC

Tulu

Westpac 1H Net Profit Ex-Notable Items A$3.48B Vs. A$3.46B>WBC.AU

4. mai 2026, 21:50 UTC

Tulu

Westpac: Some Sectors More Affected Than Others>WBC.AU

4. mai 2026, 21:50 UTC

Tulu

Westpac: Economic Impact of Middle East Conflict to Continue Through Year>WBC.AU

4. mai 2026, 21:49 UTC

Tulu

Westpac 1H Provision for Expected Credit Losses A$4.68B Vs. A$4.58B>WBC.AU

4. mai 2026, 21:44 UTC

Tulu

Westpac 1H Australia Lending Up 8% on Year>WBC.AU

4. mai 2026, 21:44 UTC

Tulu

Westpac 1H Australia Business Lending Up 16% on Year>WBC.AU

4. mai 2026, 21:43 UTC

Tulu

Westpac 1H Core Net Interest Margin 1.78% Vs. 1.80%>WBC.AU

4. mai 2026, 21:41 UTC

Tulu

Westpac 1H Australian Home Lending Up 7% on Year Excluding RAMS Portfolio>WBC.AU

4. mai 2026, 21:40 UTC

Tulu

Westpac 1H Credit Impairment Charge 10 Bps of Average Loans Vs. 6 Bps>WBC.AU

Võrdlus sarnastega

Hinnamuutus

WaVe Life Sciences Ltd Prognoos

Hinnasiht

By TipRanks

233.33% tõus

12 kuu keskmine prognoos

Keskmine 24.4 USD 233.33%

Kõrge 43 USD

Madal 13 USD

Põhineb 15 Wall Streeti analüütiku instrumendi WaVe Life Sciences Ltd 12 kuu hinnasihil - viimase 3 kuu andmed.

Hinnangu Konsensus

By TipRanks

Tugev "osta" hinnang

15 ratings

15

Osta

0

Hoia

0

Müü

Põhineb 15 analüütiku instrumendi WaVe Life Sciences Ltd aktsia reitingul - viimase 3 kuu andmed.

Tehniline skoor

By Trading Central

6.35 / 6.555Toetus ja vastupanu

Recent bearish events outweigh bullish events.

All events are bearish.

Recent bearish events outweigh bullish events.

Finantsandmed

Müügi- ja halduskulud

Tegevuskulud

Maksueelne kasum

Müük

Müügikulu

Brutokasum müügist

Intressikulud võla pealt

EBITDA

Ärikasum

$

Muud aktsiad sektorist

JNJ

Johnson and Johnson

226.12

UNH

UnitedHealth Group Inc

366.23

TMO

Thermo Fisher Scientific Inc

464.26

ISRG

Intuitive Surgical Inc

453.69

ABT

Abbott Laboratories

86.9

Live chat